logo
Share SHARE
FONT-SIZE Plus   Neg

Peregrine Cites Clinical Data To Highlight Potential Of Bavituximab

Clinical-stage biopharmaceutical company Peregrine Pharmaceuticals Inc (PPHM) Wednesday highlighted positive data from two Phase I investigator-sponsored trials and one preclinical study while evaluating the potential of bavituximab when combined with standard approved therapies in breast, liver and prostate cancers.

The company stated that in a Phase I trial of bavituximab with paclitaxel in five evaluable patients with HER-2 negative metastatic breast cancer, two patients achieved a complete tumor response, one achieved a partial response, and two had progressive disease according to Response Evaluation Criteria In Solid Tumors measurement criteria.

Additionally, the company presented data from a Phase I/II trial investigating bavituximab with sorafenib in patients with advanced hepatocellular carcinoma, in which no dose-limiting toxicities or serious adverse events were observed in the first phase of the trial.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The development of Alzheimer's drugs has been marred by a high failure rate. A U.S. study, which analyzed how the Alzheimer's clinical trials fared during the period of 2002 to 2012, revealed a failure rate of 99.6% compared to a failure rate of 81% for cancer drugs. Apple Inc. plans to invest roughly $1 billion to procure and produce original content over the next year, The Wall Street Journal reported, citing people familiar with the matter. The planned investment in Hollywood reportedly could result in as many as 10 new shows. An upcoming episode of HBO's hit TV show 'Game of Thrones' has been leaked before its scheduled premiere. It is the second confirmed leak in two weeks to hit season seven. According to the production company HBO, the episode was mistakenly made available on its streaming platforms in Spain, Sweden, Norway, Denmark and Finland.
comments powered by Disqus
RELATED NEWS
Trade PPHM now with 
Follow RTT